Spruce Biosciences/$SPRB
About Spruce Biosciences
Ticker
Industry
Employees
SPRB Metrics
$15M
-
-$0.96
2.37
-
Price and volume
Market cap
$15M
Beta
2.37
52-week high
$5.95
52-week low
$0.34
Average daily volume
848K
Financial strength
Current ratio
5.361
Quick ratio
5.065
Long term debt to equity
2.581
Total debt to equity
6.255
Interest coverage (TTM)
-121.12%
Management effectiveness
Return on assets (TTM)
-30.35%
Return on equity (TTM)
-57.55%
Valuation
Price to revenue (TTM)
2.149
Price to book
0.3
Price to tangible book (TTM)
0.3
Price to free cash flow (TTM)
-0.328
Growth
Revenue change (TTM)
-1.40%
Earnings per share change (TTM)
-33.17%
3-year earnings per share growth (CAGR)
-19.05%
What the Analysts think about SPRB
Analyst Ratings
SPRB Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
SPRB Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
SPRB News
Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder
Spruce Biosciences to wind down investment for genetic disorder drug
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Spruce Biosciences Inc For Securities Law Violations
FAQs
What’s the current market cap for Spruce Biosciences stock?
What is the P/E ratio for Spruce Biosciences stock?
Does Spruce Biosciences stock pay dividends?
No, Spruce Biosciences (SPRB) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Spruce Biosciences dividend payment date?
Spruce Biosciences (SPRB) stock does not pay dividends to its shareholders.
What is the beta indicator for Spruce Biosciences?
Spruce Biosciences (SPRB) has a beta rating of 2.37. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.